I am an associate research scientist at the Tim and Caroline Reynolds Center for Spinal Stimulation at the Kessler Foundation. During my PhD at the Toulouse Neuroimaging Center (ToNIC), my research focused on exploring appropriate measures and therapeutic interventions for the assessment and motor rehabilitation of individuals who had suffered a stroke. Now at Kessler Foundation, my research focuses on recovery from spinal cord injury by investigating the effects associated with the use of neuromodulatory interventions such as repetitive transcranial magnetic stimulation and spinal cord stimulation as adjunct therapies for neurorehabilitation.

I am an Academic Psychiatrist from the UK, with research interests in mood and anxiety disorders, and the treatment of these disorders with minimally invasive neuromodulation approaches. I also use electrophysiological and neuroimaging techniques to understand the mechanisms of action of these approaches. I recently led neuroimaging analyses for the BRIGhTMIND trial, the UK’s largest trial of transcranial magnetic stimulation (TMS) for treatment-resistant depression. I am currently developing approaches for boosting the effects of TMS by modifying the “brain state” at the time of stimulation. Key aspects of brain state include the excitability of the stimulated cortex, and active brain networks and connectivity pathways. By considering the brain state at the time of stimulation delivery, I seek to reduce the inter- and intra-individual variability characteristic of the effects of techniques such as TMS. My aim is to make well-tolerated, and popular, neuromodulation techniques more effective and more rapid for more people with difficult-to-treat mood and anxiety disorders.

Rostyslav Bubnov is working as a medical doctor in the clinical hospital ‘Pheophania’ of State Affairs Department, researcher in the Interferon Department of Zabolotny Institute of Microbiology and Virology, NAS of Ukraine, and corresponding member of Ukrainian Academy of Information. He is completing administrative responsibilities as National Representative of the European Association for Predictive, Preventive and Personalized Medicine (EPMA) in Ukraine. He received his MD in Horbachevsky Ternopil State Medical University (Ukraine) during the period of 1994-2000, and PhD in Kharkiv Medical Academy of Postgraduate Education during the period of 2009-2012. He studied medical law in International Solomon University (Kyiv) in 2013-2016. He has authored and co-authored over 100 peer-reviewed papers, 11 monographs, 20 UA patents (see http://scholar.google.com.ua/citations?user=k9YfXKwAAAAJ) and performs peer reviews and editorship for a number of journals (see https://publons.com/author/317326/rostyslav-v-bubnov) and served as expert evaluator for number of National and international projects. He is winner of number of award like President of Ukraine Award for young scientists 2012, Sentinels of Science award 2016 in Medicine, Top Reviewer 2019, etc.

Dr. Allen W. Burton is medical director of Abbott’s neuromodulation business, inclusive of Abbott’s neurostimulation and chronic pain management product portfolios. He is a board-certified anesthesiologist with an added certification in pain management and brings nearly 20 years of experience in patient care to Abbott, alongside a strong background leading large-scale clinical research programs.

Dr. Rafael Carbunaru is a distinguished professional and Vice President of Research and Development in the Neuromodulation Division at Boston Scientific Corporation. He is dedicated to improving the lives of patients worldwide through the development of innovative non-drug treatments for chronic neurological disorders and chronic pain. Dr. Carbunaru holds a bachelor's degree in electronics engineering from the Universidad Simon Bolivar and M.Sc. and Ph.D. degrees in biomedical engineering from Case Western Reserve University. With an impressive portfolio of over 60 patents, he has been recognized for his contributions to the field.

Dr. Michelle Case is a principal scientist for Medtronic’s Neuromodulation DBS research team. Dr. Case trained in electrical engineering at Northern Illinois University and completed her PhD at the University of Minnesota studying biomedical engineering. Currently, Dr. Case specializes in analyzing local field potential (LFP) data obtained from deep brain stimulation devices (DBS) and understanding how LFP sensing data relates to therapeutic outcomes and imaging. Dr. Case has been at Medtronic since 2018.